ARVN - Arvinas - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARVN is currently covered by 18 analysts with an average price target of $29.67. This is a potential upside of $22.06 (289.88%) from yesterday's end of day stock price of $7.61.

Arvinas's activity chart (see below) currently has 163 price targets and 176 ratings on display. The stock rating distribution of ARVN is 92.86% BUY and 7.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.88% with an average time for these price targets to be met of 85.96 days.

Highest price target for ARVN is $28, Lowest price target is $10, average price target is $31.88.

Most recent stock forecast was given by ELIANA MERLE from UBS on 15-May-2025.

Currently out of the existing stock ratings of ARVN, 65 are a BUY (92.86%), 5 are a HOLD (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$13.56 (182.26%)

$74

2 months 21 days ago
(15-May-2025)

6/11 (54.55%)

$14.74 (235.46%)

237

Hold

$11

$3.56 (47.85%)

$12

2 months 27 days ago
(09-May-2025)

11/17 (64.71%)

$4.39 (66.41%)

91

Buy

$19

$11.56 (155.38%)

$26

3 months 3 days ago
(02-May-2025)

1/6 (16.67%)

$11.28 (146.11%)

399

Buy

$10

$2.56 (34.41%)

$40

3 months 3 days ago
(02-May-2025)

2/3 (66.67%)

$2.28 (29.53%)

11

Buy

$16

$8.56 (115.05%)

$32

3 months 3 days ago
(02-May-2025)

1/3 (33.33%)

$8.28 (107.25%)

51

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARVN (Arvinas) average time for price targets to be met?

On average it took 85.96 days on average for the stock forecasts to be realized with a an average price target met ratio 25.88

Which analyst has the current highest performing score on ARVN (Arvinas) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on ARVN (Arvinas)?

Eliana Merle works at UBS and has 7 price targets and 6 ratings on ARVN

Which analyst is the currently most bullish on ARVN (Arvinas)?

Alethia Young with highest potential upside - $132.56

Which analyst is the currently most reserved on ARVN (Arvinas)?

Matthew Luchini with lowest potential downside - -$0

Arvinas in the News

FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales

Amicus Therapeutics FOLD reported adjusted earnings of 1 cent per share for the second quarter of 2025, which missed the Zacks Consensus Estimate of 2 cents. The company had incurred a loss of 6 cents per share in the year-ago quarter. Revenues in the second quarter totaled $154.7 million, up 22% year over year on...

Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat

Shares of Bausch Health Companies Inc. (BHC) declined 6.3% after the company reported mixed results for the second quarter of 2025. Adjusted earnings per share of 90 cents missed the Zacks Consensus Estimate of 97 cents. The earnings were up from 89 cents in the year-ago quarter. Total revenues of $2.53 billion were up 5%...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?